The evaluation of the HIV/AIDS Drug Access Initiatives in Côte D'ivoire, Senegal and Uganda: How access to antiretroviral treatment can become feasible in Africa

AIDS

Volumn 17, Issue SUPPL. 3, 2003, Pages

  Katzenstein, David ^a   Laga, Marie ^b   Moatti, Jean Paul ^c  

^a STANFORD UNIVERSITY   (United States)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; CLINICAL TRIAL; COTE D'IVOIRE; DATA ANALYSIS; DEVELOPING COUNTRY; DRUG COST; EDITORIAL; EVALUATION; GENETIC ANALYSIS; GENOTYPE; GOVERNMENT; HEALTH CARE UTILIZATION; HEALTH EDUCATION; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ORGANIZATION; POVERTY; PRIORITY JOURNAL; SENEGAL; UGANDA; VIRUS GENE; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 0043130208     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200317003-00001     Document Type: Editorial

References (27)

1. Van Praag E, Fernyak S, Katz AM. Impact of antiretroviral treatments. Informal consultation, April 1997. WHO/ASD/97.2. Geneva: WHO; 1997,
2. Hogg RS, Weber, AE, Craib KJ, Anis, AH, O'Shaughnessy MV, Schechter MT, et al. One world, one hope: the cost of providing antiretroviral therapy to all nations. AIDS 1998; 12:2203-2209.
3. Ainsworth M, Teokul W. Breaking the silence: setting realistic priorities for AIDS control in less developed countries. Lancet 2000; 356:55-60.
4. UNAIDS HIV DRUG ACCESS INITIATIVE. Providing Wider Access to HIV-related Drugs in Developing Countries. Pilot Phase. Report of the meeting on the evaluation of the initiative (Geneva 30-31 May 2000). UNAIDS, Geneva, July 2000.
5. Sachs J.D. A new global commitment to disease control in Africa. Nature Med 2001; 7:521-523.
6. Singler J, Farmer P. Treating HIV in resource-poor settings. JAMA 2002; 288:1652-1653.
7. Binswanger HP. Scaling up HIV/AIDS programs to national coverage. Science 2002; 288:2173-2176.
8. World Health Organization (WHO). International Action Plan on Scaling-Up Access to HIV Care. A Commitment to Universal Access and Action on HIV/AIDS Treatment. Geneva: WHO; December 2002.
9. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO). AIDS Epidemic Update: December 2002. Geneva: UNAIDS/WHO; 2002.
10. Weidle PJ, Malamba S, Mwebaze R, Sozi C, Rukundo G, Downing R, et al. Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance. Lancet 2002; 360:34-40.
11. Laurent C, Diakhaté N, Gueye NFN, Touré MA, Sow PS, Faye MA, et al. The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS 2002; 16:1363-1370.
12. Wainberg M, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA 1998; 279:1977-1983.
13. Kelly JA, Otto-Salaj LL, Sikkema KJ, Pinkerton SD, Bloom FR. Implications of HIV treatment advances for behavioral research on AIDS: protease inhibitors and new challenges in HIV secondary prevention. Health Psychol 1998; 17:310-319.
14. Havlir D, Vella S, Hammer S. The Global HIV Drug Resistance Surveillance Program: a partnership between WHO and International AIDS Society. AIDS 2002; 16:S7-S9.
15. Hanson S. AIDS control in sub-Saharan Africa - are more drugs and money the solution? Lancet Infect Dis 2002; 2:71-72.
16. Harries AD, Nyangulu DS, Hargreaves NJ, Kaluwa O, Salaniponi FM. Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet 2001; 358:410-414.
17. Horton R. African AIDS beyond Mbeki: tripping into anarchy. Lancet 2000; 356:1541-1542.
18. Accelerating Access Initiative. Widening access to care and support for people living with HIV/AIDS. Progress Report, June 2002. WHO/UNAIDS, Geneva, July 2002.
19. Banta D. Worldwide interest in global access to drugs. JAMA 2001; 285:2844-2846.
20. Pécoul B, Chirac P, Trouiller P, Pinel J. Access to essential drugs in poor countries: a lost battle? JAMA 1999; 281:361-367.
21. Msellati P, Vidal L, Moatti JP (eds). L'accès aux traitements du VIH/Sida en Côte d'Ivoire. Evaluation de l'Initiative Onusida/Ministère de la Santé Publique [in French]. Paris: ANRS, Coll. Sciences Sociales & Sida; 2001.
22. Hammer SM (ed.). Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach. Geneva: World Health Organization; 2002.
23. Desclaux A, Lanièce I, Ndoye I, Taverne B (eds). L'Initiative Sénégalaise d'Accès aux Médicaments Antirétroviraux. Analyses économiques, sociales, comportementales et médicales [in French]. Paris: ANRS, Coll. Sciences Sociales & Sida; 2002.
24. De Cock KM, Mbori-Ngacha D, Marum E. Shadow on the continent: public health and HIV/AIDS in Africa in the 21st century. Lancet 2002; 360:67-72.
25. Galvão J. Access to antiretroviral drugs in Brazil. Lancet 2002; 360:1862-1865.
26. President's Emergency Plan for AIDS Relief announced on January 28, 2003, See at: www.whitehouse.gov/news/releases/2003
27. Blower SM, Farmer P. Predicting the public health impact of antiretrovirals: preventing HIV in developing countries. AIDScience 2003; 3 (accessed at http://aidscience.org/Articies/AIDScience033.asp).